May 2020

Abstract 12: Survival after IV vs. IO amiodarone, lidocaine, or placebo in OOHCA

EMA 2020 May26 Chapters

  1. Introduction4:59
  2. Ultra Summary18:41
  3. Time To Talk A Little Nerdy: Bayes and Bayes’ Theorem17:58
  4. Farewell1:14
00:00
05:11
Sign in or subscribe to listen

No me gusta!

The flash player was unable to start. If you have a flash blocker then try unblocking the flash content - it should be visible below.

Lance M. -

raises the question whether patients who get IO rather than IV access in the field have worse "vascular health" and whether that reflects their poorer underlying health status from the start. obesity, severe shock, atherosclerosis, prolonged time until start of CPR, IVDU, elderly, etc., are risk factors for harder PIV placement and those are also risk factors for poorer outcomes. IO vs IV survival may just be proxy for that.

To join the conversation, you need to subscribe.

Sign up today for full access to all episodes and to join the conversation.

To earn CME for this chapter, you need to subscribe.

Sign up today for full access to all episodes and earn CME.

6 AMA PRA Category 1 Credits™ certified by PIM

  1. Quiz Not Required
  2. Complete Evaluation
  3. Print Certificate